TruAlt Bioenergy Limited
TruAlt Bioenergy Limited (TRUALT) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Fast Moving Consumer Goods›Fast Moving Consumer Goods›Agricultural Food & other Products›Other Agricultural Products
trualtbioenergy.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-02
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Sales | 304 Cr | 115 Cr | 713 Cr | 596 Cr | 627 Cr |
| Operating expenses (approx.) | 262 Cr | 119 Cr | 579 Cr | 477 Cr | 494 Cr |
| EBITDA | 42 Cr | -5 Cr | 134 Cr | 119 Cr | 133 Cr |
| OPM % | 13.7% | -4.0% | 18.8% | 19.9% | 21.2% |
| Other income | 23 Cr | 15 Cr | 18 Cr | 31 Cr | 15 Cr |
| Interest | 38 Cr | 39 Cr | 40 Cr | 44 Cr | 44 Cr |
| Depreciation | 21 Cr | 21 Cr | 22 Cr | 23 Cr | 25 Cr |
| Profit before tax | 6 Cr | -49 Cr | 90 Cr | 84 Cr | 78 Cr |
| Tax % | 18.5% | 22.8% | 22.9% | 27.2% | 24.4% |
| Net profit | 5 Cr | -38 Cr | 69 Cr | 61 Cr | 59 Cr |
| EPS (₹) | ₹0.67 | ₹-5.37 | ₹8.07 | ₹6.99 | ₹6.67 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2026 | TTM |
|---|---|---|
| Sales | 1,728 Cr | Sign in for TTM |
| Operating expenses (approx.) | 1,438 Cr | Sign in for TTM |
| EBITDA | 290 Cr | Sign in for TTM |
| OPM % | 16.8% | Sign in for TTM |
| Other income | 86 Cr | Sign in for TTM |
| Interest | 160 Cr | Sign in for TTM |
| Depreciation | 86 Cr | Sign in for TTM |
| Profit before tax | 130 Cr | Sign in for TTM |
| Tax % | 25.5% | Sign in for TTM |
| Net profit | 97 Cr | Sign in for TTM |
| EPS (₹) | ₹12.30 | Sign in for TTM |
| Dividend payout % | 0.0% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2026 |
|---|---|
| Equity capital | 86 Cr |
| Reserves | 1,435 Cr |
| Borrowings | 1,646 Cr |
| Other liabilities | 554 Cr |
| Total liabilities | 3,778 Cr |
| Fixed assets (net) | 2,052 Cr |
| CWIP | 68 Cr |
| Investments | 4 Cr |
| Inventories | 528 Cr |
| Trade receivables | 406 Cr |
| Cash & bank | 88 Cr |
| Other assets | 632 Cr |
| Total assets | 3,778 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2026 |
|---|---|
| Cash from operating activity | -289 Cr |
| Cash from investing | -420 Cr |
| Cash from financing | 648 Cr |
| Net cash flow | -62 Cr |
| Free cash flow (OCF − Capex) | -800 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2026 |
|---|---|
| ROCE % | 9.0% |
| ROE % | 6.1% |
| Debtor days | 86 |
| Inventory days | 182 |
| Days payable | 94 |
| Cash conversion cycle | 174 |
| Debt / equity | 1.08 |
| Current ratio | 1.36 |
| Net debt / EBITDA | 5.38 |
Compare with peers
Loading peers…